Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 10 9 /L to < 100 × 10 9 /L) at Baseline

Paola Guglielmelli, MD, Jean-Jacques Kiladjian, MD PhD, Alessandro M. Vannucchi, MD, Ming-hui Duan, MD, Haitao Meng, MD PhD, Ling Pan, MD PhD, Guangsheng He, MD PhD, Srdan Verstovsek, MD PhD, Françoise Boyer-Perrard, MD, Fiorenza Barraco, MD, Dietger Niederwieser, MD PhD, Anna Marina Liberati, MD, Claire Harrison, DM, FRCP, FRCPath, Pantelia Roussou, MSc, Monika Wroclawska, MD, Kevin Majidi, Peter AW te Boekhorst, MD PhD, Heinz Gisslinger, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-137742

Published: 2020

Journal Articles

A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-137319

Published: 2020

Journal Articles

Trial in Progress: The Phase III, Randomized, Open-Label, Multicenter COMMODORE 2 Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria Not Previously Treated with Complement Inhibitors

Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Guangsheng He, MD PhD, Talha Munir, MBBS, Jeffrey Pu, MDPhD, Antonio Risitano, Alexander Röth, MD, Camelia S. Sima, MD, Anita Appius, PhD, Alexandre Sostelly, PhD, Sasha Sreckovic, MD, Charlotte Vignal, PhD, Jun-Ichi Nishimura, MD PhD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-136647

Published: 2020

Journal Articles

Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases

Ming Hong, MD PhD, Shuai Wang, MD PhD, Han Zhu, MD, Rong Wang, Jianyong Li, MD PhD, Guangsheng He, MD PhD

Blood (2017) 130 (Supplement 1): 5230.

https://doi.org/10.1182/blood.V130.Suppl_1.5230.5230

Published: 2017

Journal Articles

Subsets and Function Changes of Th Cells in the Bone Marrow of Patients with Immune Related Pancytopenia.

Guangsheng He, MD, PhD, Xiuli Wang, PhD, De Pei Wu, MD, Ph.D, Aining Sun, PhD, Zhengming Jin, PhD

Blood (2005) 106 (11): 3762.

https://doi.org/10.1182/blood.V106.11.3762.3762

Published: 2005

Journal Articles

Research of Subset and Function of Th Cells in Bone Marrow of Myelodysplastic Syndrome Patients.

Xiuli Wang, PhD, De Pei Wu, MDPhD, Guangsheng He, MD, PhD, Miao Miao, PhD, Aining Sun, PhD

Blood (2005) 106 (11): 4913.

https://doi.org/10.1182/blood.V106.11.4913.4913

Published: 2005

NARROW

The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 10 9 /L to < 100 × 10 9 /L) at Baseline

A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)

Trial in Progress: The Phase III, Randomized, Open-Label, Multicenter COMMODORE 2 Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria Not Previously Treated with Complement Inhibitors

Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases

Subsets and Function Changes of Th Cells in the Bone Marrow of Patients with Immune Related Pancytopenia.

Research of Subset and Function of Th Cells in Bone Marrow of Myelodysplastic Syndrome Patients.

Email alerts

ASH Publications

American Society of Hematology

The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 10 9 /L to < 100 × 10 9 /L) at Baseline

A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)

Trial in Progress: The Phase III, Randomized, Open-Label, Multicenter COMMODORE 2 Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Adult and Adolescent Patients with Paroxysmal Nocturnal Hemoglobinuria Not Previously Treated with Complement Inhibitors

Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases

Subsets and Function Changes of Th Cells in the Bone Marrow of Patients with Immune Related Pancytopenia.

Research of Subset and Function of Th Cells in Bone Marrow of Myelodysplastic Syndrome Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only